Kindex Therapeutics, LLC
Records under this name other than patents Kindex Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Kindex Therapeutics, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,410,178 | CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods Formerly held Lapsed on the fee record Ended Apr 2, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 2, 2025 | USPTO record |
| US 8,410,179 | Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods Formerly held Lapsed on the fee record Ended Apr 2, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 2, 2025 | USPTO record |
| US 8,829,056 | Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods Formerly held Lapsed on the fee record Ended Sep 9, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2022 | USPTO record |